Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Histiocytosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We reviewed 73 biopsies from 42 patients showing involvement by histiocytosis from a variety of organ systems, including bone (16), retroperitoneum (11), skin (19), orbit (6), brain (5), lung (6), cardiac structures (2), epidural soft tissue (3), oral cavity (2), subcutaneous soft tissue (2), and testis (2).
|
29192649 |
2018 |
Mydriasis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
In the univariate analysis, factors associated with an unfavorable outcome were preoperative coagulopathy, midline shift of the brain ≥ 5 mm, basal cistern effacement, moderate to severe TBI, hypotension, fixed and dilated pupils, surgical site infection, hematocrit < 30% on admission, coup contusion, and subdural hematoma.
|
30544306 |
2018 |
orbit (eye disorders)
|
0.010 |
Biomarker
|
group |
BEFREE |
We reviewed 73 biopsies from 42 patients showing involvement by histiocytosis from a variety of organ systems, including bone (16), retroperitoneum (11), skin (19), orbit (6), brain (5), lung (6), cardiac structures (2), epidural soft tissue (3), oral cavity (2), subcutaneous soft tissue (2), and testis (2).
|
29192649 |
2018 |
Histiocytic syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
We reviewed 73 biopsies from 42 patients showing involvement by histiocytosis from a variety of organ systems, including bone (16), retroperitoneum (11), skin (19), orbit (6), brain (5), lung (6), cardiac structures (2), epidural soft tissue (3), oral cavity (2), subcutaneous soft tissue (2), and testis (2).
|
29192649 |
2018 |
Depression, Bipolar
|
0.010 |
Biomarker
|
disease |
BEFREE |
Brain 5-HT1A binding potential (BP(F) = B(max)/K(D), where B(max) = total available receptors, and 1/K(D) = ligand affinity) was measured in 32 currently depressed, medication-free BD subjects and 47 controls.
|
19278673 |
2009 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The results of the present study suggest that the transcription factor POU6F1 could be a new molecular target for treatment of this cancer.
|
19874398 |
2009 |
Adenocarcinoma, Clear Cell
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.
|
19874398 |
2009 |
Ovarian adenocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.
|
19874398 |
2009 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The results of the present study suggest that the transcription factor POU6F1 could be a new molecular target for treatment of this cancer.
|
19874398 |
2009 |